1. Home
  2. AOSL vs KURA Comparison

AOSL vs KURA Comparison

Compare AOSL & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha and Omega Semiconductor Limited

AOSL

Alpha and Omega Semiconductor Limited

HOLD

Current Price

$26.39

Market Cap

973.9M

Sector

Technology

ML Signal

HOLD

Logo Kura Oncology Inc.

KURA

Kura Oncology Inc.

HOLD

Current Price

$11.89

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOSL
KURA
Founded
2000
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
973.9M
1.1B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
AOSL
KURA
Price
$26.39
$11.89
Analyst Decision
Buy
Buy
Analyst Count
3
11
Target Price
$24.00
$25.56
AVG Volume (30 Days)
571.0K
1.7M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$342,291,000.00
$67,482,000.00
Revenue This Year
N/A
$28.28
Revenue Next Year
$6.41
$106.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
25.24
52 Week Low
$17.01
$7.36
52 Week High
$54.34
$12.90

Technical Indicators

Market Signals
Indicator
AOSL
KURA
Relative Strength Index (RSI) 36.17 63.99
Support Level $19.38 $7.71
Resistance Level $46.93 $12.34
Average True Range (ATR) 2.05 0.59
MACD -0.50 0.29
Stochastic Oscillator 5.35 74.14

Price Performance

Historical Comparison
AOSL
KURA

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries. It operates in one operating segment: the design, development and supply of power semiconductor products for computing, consumer electronics, communication and industrial applications.

About KURA Kura Oncology Inc.

Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.

Share on Social Networks: